You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

CLINICAL TRIALS PROFILE FOR INNOPRAN XL

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for innopran xl

Subscribe to access the full database, or Subscribe
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00934947 ↗	Burn Healing and Analgesia With Propranolol	Completed	University of North Carolina, Chapel Hill	Phase 2	2009-07-01	The purpose of this study is to investigate the ability of propranolol to decrease pain and improve recovery in burn patients with a common genotype.
NCT01007084 ↗	TRAUMA HELP: Healing and Analgesia With Propranolol	Withdrawn	University of North Carolina, Chapel Hill	Phase 2	2009-10-01	The purpose of this study is to determine whether propranolol can decrease pain symptoms in a common subset of patients admitted to a trauma center after injury.
NCT01222091 ↗	Study on the Effect of a Beta Blocker on Increased Sensitivity to Pain in Humans Caused by Opioids	Completed	Stanford University	Phase 2	2009-02-01	This research study explores whether a beta-blocker (propranolol) can prevent a person from becoming more sensitive to pain after administration of an opioid (remifentanil). Beta blockers inhibit the sympathetic (fight or flight) response and are often used to treat angina and high blood pressure. In a previous study in human volunteers, the investigators demonstrated an increased sensitivity to pain after a 60-minute infusion of the opioid remifentanil. The goal of this study is to identify a possible inhibitor of this phenomenon.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for innopran xl

Condition Name

Chart
Table

Condition Name for innopran xl
Intervention	Trials
Autism Spectrum Disorder	1
Burns	1
Hyperalgesia	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for innopran xl
Intervention	Trials
Hyperalgesia	1
Wounds and Injuries	1
Burns	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for innopran xl

Trials by Country

Map
Table

Trials by Country for innopran xl
Location	Trials
United States	6
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for innopran xl
Location	Trials
North Carolina	2
California	1
Pennsylvania	1
District of Columbia	1
Missouri	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for innopran xl

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for innopran xl
Clinical Trial Phase	Trials
Phase 2	3
Early Phase 1	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for innopran xl
Clinical Trial Phase	Trials
Completed	3
Withdrawn	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for innopran xl

Sponsor Name

Chart
Table

Sponsor Name for innopran xl
Sponsor	Trials
University of North Carolina, Chapel Hill	2
Stanford University	1
United States Department of Defense	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for innopran xl
Sponsor	Trials
Other	4
U.S. Fed	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.